Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CytoMed Therapeutics Limited - Ordinary Shares (NQ: GDTC )

1.810 -0.160 (-8.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 43,082
Open 1.890
Bid (Size) 1.710 (9)
Ask (Size) 1.900 (10)
Prev. Close 1.970
Today's Range 1.680 - 1.990
52wk Range 1.680 - 5.500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are a hot topic on Friday as we check out all of the stories affecting shares on the last day of trading this week! 
Via InvestorPlace
CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers
Another Patent Granted for CytoMed's Allogeneic Induced Pluripotent Stem Cell (“iPSC”)-derived Hybrid Gamma Delta Natural Killer T (γδ NKT) cells technology 
From CYTOMED THERAPEUTICS LIMITED
Via GlobeNewswire

Performance

YTD
-58.96%
-58.96%
1 Month
-10.86%
-10.86%
3 Month
-13.81%
-13.81%
6 Month
-51.21%
-51.21%
1 Year
-55.53%
-55.53%

More News

Read More
Navigating the Challenges Facing an Aging Global Population: How CytoMed Seeks to Help Boost Cartilage Regeneration
Via Spotlight Growth
CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration
Via ACCESSWIRE
CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies
From CYTOMED THERAPEUTICS LIMITED
Via GlobeNewswire
CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair
From CYTOMED THERAPEUTICS LIMITED
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
US Stocks Gain; Uber Posts Upbeat Sales
Via Benzinga
Topics Stocks
Exposures US Equities
Why Container Store Group Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
From CYTOMED THERAPEUTICS LIMITED
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Singapore’s Journey to Becoming a Biotech Powerhouse
Via Spotlight Growth
Topics Economy
Exposures Economy
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
CytoMed Expands Research Collaboration into China After Entering Into MOU
Via ACCESSWIRE
Singapore’s Leap into the Future of Cell and Gene Therapies
Via Spotlight Growth
Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal
Via Talk Markets
The Dawn of a New Era in Immunotherapy for Cancers: Understanding CytoMed Therapeutics’ (NASDAQ: GDTC) iPSC-Derived Gamma Delta NKT Cell Technology
Via Spotlight Growth
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.